West Pharmaceutical Services (WST) Work In Process (2010 - 2012)

West Pharmaceutical Services (WST) has reported Work In Process for 3 consecutive years, with $25.3 million the latest figure, recorded in Q2 2012.

• Quarterly Work In Process rose 7.2% year-over-year to $25.3 million in Q2 2012, while the trailing twelve-month figure through Jun 2012 was $25.3 million (up 7.2% YoY) and the FY2011 annual result came in at $19.6 million, down 8.41% from the prior year.
• Work In Process advanced to $25.3 million in Q2 2012 per WST's latest filing, from $19.6 million in the prior quarter.
• Over the last five years, Work In Process for WST reached as high as $25.3 million in Q2 2012 and fell as low as $19.6 million in Q4 2011.
• A 3-year average of $22.3 million and a median of $21.7 million in 2011 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2011 — Work In Process decreased 8.41% — and 2012, when it climbed 7.2%.
• Year by year, Work In Process stood at $21.4 million in 2010, then slipped by 8.41% to $19.6 million in 2011, then gained by 29.08% to $25.3 million in 2012.
• According to Business Quant data, Work In Process over the past three periods registered $25.3 million, $19.6 million, and $21.7 million for Q2 2012, Q4 2011, and Q3 2011 respectively.